Related Experiment Video
Updated: Apr 3, 2026

Three-Dimensional Reconstruction of Orbital Fractures
Published on: May 16, 2025
Comparison of Treatment Outcomes Between Early and Delayed Primary Repair of Orbital Blowout Fractures: A
Kervin Luke D Dellosa1,2, Min Kyu Yang1, Ho-Seok Sa1
1Department of Ophthalmology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
Objectives:
To compare clinical outcomes between early (≤4 wk) and late (≥4 wk) surgical repair of orbital blowout fractures (BOF) in adults.
Methods:
A retrospective review was conducted on 172 adults undergoing primary orbital BOF repair. Patients were categorized into early (n=123) and late (n=49) repair groups. Preoperative and postoperative outcomes were compared, including extraocular muscle (EOM) motility, enophthalmos, diplopia, infraorbital hypesthesia, operative time, and complications.
Results:
Preoperative assessments revealed that patients in the early repair group exhibited worse EOM motility (-0.93 versus -0.49; P=0.005), whereas those in the late repair group presented with greater enophthalmos (1.77 versus 1.33 mm; P=0.006). Both groups demonstrated significant postoperative improvements, resulting in similar final outcomes for EOM motility (-0.12 versus -0.04; P=0.164) and enophthalmos (0.23 mm versus 0.23 mm; P>0.999). Residual diplopia resolved in all patients by 12 months (mean recovery: 64.57 versus 64.65 d; P=0.997). Infraorbital hypesthesia rates (1.6% versus 2.0%; P=0.851) and recovery times (74.00 versus 69.50 d; P=0.882) were comparable between groups. There were no significant differences in operative time (46.54 versus 46.45 min; P=0.984) or incidence of complications-including new diplopia, sensory deficits, or haematoma-between early and delayed repair.
Conclusions:
Delayed BOF repair conducted after 4 weeks achieved equivalent functional, cosmetic, and neurosensory outcomes compared with early intervention, with no increase in operative risks. Delayed repair remains a viable and effective option for patients presenting with persistent diplopia or late-onset enophthalmos.

